Skip to main content
Ipsen Home Page
Press shift tab to select search category
Loading...
  • Careers arrow down
      < Back
    • Careers
    • Careers
    • Working at Ipsen
    • Culture
  • Press shift tab to select search category
    Loading...
  • Ελληνικά  EL     English  EN     EN  arrow_down
    • Ελληνικά EL
    • English EN
  •  Greece
    < Back
    • Global EN FR
    • Annual Report EN FR
    • Americas
    • Asia Pacific
    • Europe
    • Middle East & Africa
    • United States
    • Brazil
    • Canada
    • Mexico
    • Australia
    • China
    • Singapore
    • South Korea
    • Japan
    • Belgium
    • Ukraine
    • UK
    • Germany
    • France
    • Nordics
    • Greece
    • Italy
    • Netherlands
    • Spain
    • Poland
    • Russia
    • Czech Republic
    • Switzerland
    • Austria
    • UAE & Gulf
  • Home
  • Company
      < Back
    • Company
    • Company
    • History
    • Fondation Ipsen
  • Science
      < Back
    • Science
    • Oncology
    • Rare Disease
    • Neuroscience
    • Products
  • Sustainability
      < Back
    • Sustainability
    • Sustainability
    • Environment
    • Patients
    • People
    • Governance
  • Patients
      < Back
    • Patients
    • Patients
    • Together for Oncology
    • Together for Rare Disease
    • Together for Neuroscience
    • Lay Summaries
    • Collaborate with us
  • Our Stories
      < Back
    • Our Stories
    • Our Stories
    • CSR
    • Our People
    • Patient Centricity
  • Useful Links

Post navigation

Previous
Next

Cabometyx® (cabozantinib)

Cabometyx® (cabozantinib)

- 04 March 2024 - 0 mins read

Post navigation

Previous
Next

Related Products

Kayfanda® (odevixibat)
05 December 2024 0 mins read

Kayfanda® (odevixibat)
Somatuline Autogel®(lanreotide acetate)
04 March 2024 0 mins read

Somatuline Autogel®(lanreotide acetate)
Iqirvo<sup>®</sup> (elafibranor)
04 March 2024 0 mins read

Iqirvo® (elafibranor)
Dysport<sup>®</sup> (abobotulinumtoxinA)
04 March 2024 0 mins read

Dysport® (abobotulinumtoxinA)
Decapeptyl<sup>®</sup> (triptorelin pamoate or acetate)
04 March 2024 0 mins read

Decapeptyl® (triptorelin pamoate or acetate)
Cometriq<sup>®</sup> (cabozantinib)
04 March 2024 0 mins read

Cometriq® (cabozantinib)
Bylvay<sup>®</sup> (odevixibat)
04 March 2024 0 mins read

Bylvay® (odevixibat)

IPN price

€163.70

 €2.90 (1.80%)

  • Careers
  • Company
  • Sustainability
  • Patients
  • Contact Us
Ipsen logo
LinkedIn Instagram Facebook Youtube
  • Terms and Conditions
  • Cookie Policy
  • Privacy Policy
  • Ipsen Standard Terms & Conditions Of Purchase Orders

Copyright © Ipsen Pharma. All rights reserved - 2025

You are now leaving the Ipsen group website.To continue, please click on Continue?

Continue